XML 31 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Geographic and Product Data
 3 Months Ended
Mar. 30, 2012
Geographic and Product Data

Note 10 — Geographic and Product Data

 

The Company markets and sells its products in approximately 60 countries and has manufacturing sites in the United States, Switzerland and Japan. Other than the United States, Japan, Korea, and China, the Company does not conduct business in any country in which its sales exceed 5% of consolidated sales. Sales are attributed to countries based on location of customers. The composition of the Company’s net sales to unaffiliated customers is set forth below (in thousands):

    Three Months Ended
    March 30, 2012   April 1, 2011
United States   $ 3,174     $ 3,533  
Japan     3,857       3,845  
Korea     1,903       1,384  
China     2,106       1,204  
Other     4,469       4,883  
Total   $ 15,509     $ 14,849  

 

 

 

 

100% of the Company’s sales are generated from the ophthalmic surgical product segment and therefore the Company operates as one operating segment for financial reporting purposes. The Company’s principal products are implantable Collamer lenses (“ICLs”) used in refractive surgery and intraocular lenses (“IOLs”) used in cataract surgery. The composition of the Company’s net sales by product line is as follows (in thousands):

 

    Three Months Ended
    March 30, 2012   April 1, 2011
IOLs   $ 6,358     $ 7,120  
ICLs     8,605       6,897  
Core products     14,963       14,017  
Other Surgical Products     546       832  
Total   $ 15,509     $ 14,849  

 

 

The Company sells its products internationally, which subjects the Company to several potential risks, including fluctuating foreign currency exchange rates (to the extent the Company’s transactions are not in U.S. dollar), regulation of fund transfers by foreign governments, United States and foreign export and import duties and tariffs, and political instability.